Olympus Corp. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
16,425
8,934
70,800
62,481
76,665
20,117
Depreciation, Depletion & Amortization
46,307
50,640
49,779
54,290
52,913
58,669
Other Funds
2,454
2,634
2,261
3,553
2,394
21,801
Funds from Operations
75,787
100,787
42,668
101,793
107,373
56,985
Changes in Working Capital
3,399
33,976
5,953
259
12,227
9,958
Net Operating Cash Flow
72,388
66,811
48,621
102,052
95,146
66,943
Capital Expenditures
32,584
41,098
56,409
60,208
63,409
Sale of Fixed Assets & Businesses
4,854
254
-
4,397
8,046
Purchase/Sale of Investments
3,978
1,519
2,761
42,239
7,047
Net Investing Cash Flow
20,273
39,612
52,897
20,814
53,312
Cash Dividends Paid - Total
-
-
3,422
5,818
9,583
Issuance/Reduction of Debt, Net
149,884
67,539
28,174
34,150
35,418
Net Financing Cash Flow
39,693
70,185
33,870
43,615
51,058
Net Change in Cash
25,562
41,535
43,486
33,086
8,226
Free Cash Flow
45,046
30,856
1,801
53,387
46,291
Net Assets from Acquisitions
-
798
-
41
8,636
Other Sources
3,524
511
751
19
5,647
Change in Capital Stock
112,645
12
13
8
3,663
Exchange Rate Effect
13,140
1,451
5,340
4,537
998
Other Uses
45
-
-
7,220
2,007

About Olympus

View Profile
Address
Shinjuku Monolith
Tokyo Tokyo 163
Japan
Employees -
Website http://www.olympus.co.jp
Updated 07/08/2019
Olympus Corp. is engaged in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical Systems, Life Sciences and Industrial, Imaging Systems, Information and Communications, and Others. The Medical Systems segment covers endoscopes, and endoscopic surgery and therapy.